Bariatric surgery and type 2 diabetes mellitus: Surgically induced remission

Journal of Diabetes Science and Technology

Volumn 2, Issue 4, 2008, Pages 685-691

  Tejirian, Talar ^a   Jensen, Candice ^a   Dutson, Erik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bariatric; Gastric bypass; Remission; Type 2 diabetes

Indexed keywords

EID: 78449293207     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200420     Document Type: Article

References (55)

1. Ferchak C V, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes-a systematic review. Diabetes Metab Res Rev. 2004;20(6):438-45.
2. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15(4):462-73.
3. Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am. 2007;91(3):393-414.
4. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15(4):474-81.
5. Brown SA, Upchurch S, Anding R, Winter M, Ramìrez G. Promoting weight loss in type II diabetes. Diabetes Care. 1996;19(6):613-24.
6. Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med. 2003;20(9):693-702.
7. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care. 2006;9(4):497-507.
8. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. September 1998. www.nhlbi.nih.gov/guidelines/obesity/ob-gdlns.htm Accessed January 24, 2008.
9. Centers for Disease Control and Prevention, National Center for Health Statistics. Faststats. http://www.cdc.gov/nchs/fastats/overwt.htm Accessed January 24, 2008.
10. Weight Control Information Network. Bariatric surgery for severe obesity. http://win. niddk.nih.gov/publications/gastric.htm Accessed January 24, 2008.
11. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, de Ramon RA, Israel G, Dolezal JM, Dohm L. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-50.
12. Long SD, O'Brien K, MacDonald KG Jr, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes; A longitudinal interventional study. Diabetes Care. 1994;17(5):372-5.
13. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358-63.
14. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52(5):1098-103.
15. Vidal J, Ibarzabal A, Nicolau J, Vidov M, Delgado S, Martinez G, Balust J, Morinigo R, Lacy A. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17(8):1069-74.
16. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitis. Ann Surg. 2002;236(5):554-9.
17. De Maria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235(5):640-5.
18. Fobi MA, Lee H, Holness R, Cabinda D. Gastric bypass operation for obesity. World J Surg. 1998;22(9):925-35.
19. Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity; technique and preliminary results of our frst 400 patients. Arch Surg. 2000;135(9);1029-33.
20. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52.
21. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-37.
22. Erratum in: JAMA 2005;292(14):1728.
23. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467-84; discussion 84-5.
24. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. Biliopancreatic diversion. World J Surg. 1998;22(9):936-46.
25. Doar JW, Wilde CE, Thompson ME, Sewell PF. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus. Lancet. 1975;1(7919):1263-6.
26. 25: Deitel M, Sidhu PS, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese [abstract]. Obes Surg. 1991;1:113-4.
27. Neve HJ, Soulsby CT, Whitely GS, Kincey J, Taylor T V. Resolution of diabetes following vertical gastroplasty in morbidly obese patients. Obes Surg. 1993;3(1):75-8.
28. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515-29.
29. Holdstock C, Engström BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88(70):3177-83.
30. Kim MS, Namkoong C, Kim HS, Jang PG, Kim Pak YM, Katakami H, Park JY, Lee KU. Chronic central administration of ghrelin reverses the effects of leptin. Int J Obes Relat Metab Disord. 2004;28(10):1264-71.
31. Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg. 2004;70(1):1-4; discussion 4-5.
32. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfne A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 2003;11(8):919-24.
33. Näslund E, Backman L, Holst JJ, Theodorsson E, Hellström PM. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8(3):253-60.
34. Ikramuddin S, Leslie D, Whitson BA, Kellogg TA. Energy metabolism and biochemistry of obesity. In: Rosenthal RJ, Jones DB, editors. Weight loss surgery: a multidisciplinary approach. Edgemont (PA): Matrix Medical Communications; 2008. 17-23.
35. Nauck MA, Meier JJ, Creutzfieldt W. Incretins and their analogues as new antidiabetic drugs. Drug News Perspect. 2003;16(7):413-22.
36. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108-14.
37. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-42.
38. Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138(2):283-90.
39. Greenway SE, Greenway FL 3rd, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137(10):1109-17.
40. Verdich C, Flint A, Gutzwiller JP, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ, Astrup A. A metaanalysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab. 2001;86(9):4382-9.
41. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15(9):1258-64.
42. Patriti A, Aisa MC, Annetti C, Sidoni A, Galli F, Ferri I, Gullà N, Donini A. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced proglucagon gene expression and L-cell number. Surgery. 2007;142(1):74-85.
43. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-30.
44. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab. 2003;88(7):2999-3002.
45. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90(1):359-65.
46. Stratis C, Alexandrides T, Vagenas K, Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg. 2006;16(6):752-8.
47. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741-9.
48. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1-11.
49. Pacheco D, de Luis DA, Romero A, González Sagrado M, Conde R, Izaola O, Aller R, Delgado A. The effects of duodenaljejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194(2):221-4.
50. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997;21 Suppl 1:S5-9.
51. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16(6):397-415.
52. Hickey MS, Pories WJ, MacDonald KG Jr, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998;227(5):637-43; discussion 643-4.
53. Schirmer B. Laparoscopic bariatric surgery. Surg Endosc. 2006;20 Suppl 2:S450-5.
54. Rendon SE, Pories WJ. Quality assurance in bariatric surgery. Surg Clin North Am. 2005;85(4):757-71, vi-vii.
55. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectivemess of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord. 2003;27(10):1167-77.